Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08 March 2025 - 12:30AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2025
Commission File Number 001-40996
MDXHEALTH SA
(Translation of registrant’s name into English)
CAP Business Center
Zone Industrielle des Hauts-Sarts
4040 Herstal, Belgium
+32 4 257 70 21
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
CEO PURCHASES SHARES OF MDXHEALTH
MDxHealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”)
announced today that on March 6, 2025, Michael McGarrity, Chief Executive Officer and a member of the Board of Directors of the Company,
informed the Company that he had purchased an aggregate of 50,000 of the Company’s ordinary shares for a total aggregate purchase
price of approximately $80,000.
This information is being
furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference
in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise set forth herein
or as shall be expressly set forth by specific reference in such a filing. Mr. McGarrity is not generally required to disclose his trading
in the Company’s ordinary shares (other than in limited circumstances, including in the Company’s Annual Report on Form 20-F)
and does not assume any obligation to disclose any additional purchases or sales, except where required by law.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
MDXHEALTH SA |
|
|
|
Date: March 7, 2025 |
By: |
/s/ Michael McGarrity |
|
|
Name: |
Michael McGarrity |
|
|
Title: |
Chief Executive Officer |
2
MDxHealth (NASDAQ:MDXH)
Historical Stock Chart
From Feb 2025 to Mar 2025
MDxHealth (NASDAQ:MDXH)
Historical Stock Chart
From Mar 2024 to Mar 2025